Sampatrilat, aslo known as UK-81252, is a NEP/ACE inhibitor potentially for the treatment of hypertension and heart failure. References: . Machowska A, Juszczak K, Novak P, Thor P. The natriuretic peptide neurohormonal system modulation by vasopeptidase inhibitors--the novel therapeutical approach of hypertension treatment. Folia Med Cracov. 2009;50(3-4):35-42. Review. PubMed PMID: 21853869.

纯度：≥98%

CAS：129981-36-8